1Ang DS,Welsh P,Watt P,et al.Serial changes in adiponectin and BNP in ACS patients:paradoxical associations with each other and with prognosis[J].Clin Sci,2009,117(1):41.
2O′Donoghue M,Morrow DA,Sabatine MS,et al.Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial[J].Circulation,2006,113(14):1745.
6Kitagawa T,Yamamoto H,Horiguchi J,et al.Characterization of Noncalcified Coronary Plaques and Identification of Culprit Lesions in Patients With Acute Coronary Syndrome by 64-Slice Computed Tomography[J].J Am Coll Cardiol Img,2009,2(2):153.
7Raffel OC,Tearney GJ,Gauthier DD,et al.Relationship Between a Systemic Inflammatory Marker,Plaque Inflammation,and Plaque Characteristics Determined by Intravascular Optical Coherence Tomography[J].Arterioscler Thromb Vasc Biol,2007,27(8):1820.
9Serruys PW,Garcia-Garcia HM,Buszman P,et al.Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque[J].Circulation,2008,118(11):1172.
10Ambrose JA,Martinez EE.A new paradigm for plaque stabilization[J].Circulation,2002,105(16):2000.
3HOTTA K, FUNAHASHI T, ARITA Y, et al. Plasma concentrations of a novel, adipose specific protein,adiponectin,in type 2 diabetic patients[J]. Arterioscler Throm Vase Biol,2000,20(6) : 1595-1599.
4KUMADA M, KIHARA S, SUMITSUJI S, et al. Association of hypoadiponectinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc Biol, 2003,23 (1):85-89.
5ENGELI S, FELDPAUSCH M, GORZELNIAK K, et al.Association between adiponectin and mediators of inflammation in obese women[J]. Diabetes, 2003,52(4):942-947.
6MATSUDA M, SHIMOMURA I, SATA M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis[J]. J Biol Chem, 2002, 277 (40): 37487-37491.
7SHIBATA M, ENDO S, INADA K, et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction [J]. J Interferon Cytokine Res, 1997,17(2) : 145-150.
8KUMADA M, KIHARA S, OUCHI N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages[J]. J Interferon Cytokine Res, 1997,17(3):145-150.
